Meningococcal Vaccines market is projected to grow at a CAGR of 2.5% by 2034: Visiongain
Visiongain has published a new report entitled Meningococcal Vaccines Market Report 2024-2034: Forecasts by Type (Polysaccharide Vaccines, Conjugate Vaccines, Combination Vaccines, Men B Vaccines), by Serogroups (A, B, C, Y, W-135 Vaccines, Serogroup B Vaccines), by Brands (Menactra, Menveo, Nimenrix, Bexsero, Trumenba), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVI
Saudi Arabia New Zealand Walvax Biotechnology Co Ltd Drug Administration Global Meningococcal Initiative World Health Assembly
Source: yahoo.com